The Houston Methodist System comprises a leading academic medical center located in the Texas Medical Center and seven community hospitals serving the Greater Houston area. Houston Methodist Hospital, the system’s flagship, has been ranked #1 hospital in Texas by U.S. News and World Report every year since the award began and is one of the top nationally ranked Honor Roll hospitals (currently #16). The Department of Medicine encompasses a number of nationally ranked programs, including Gastroenterology (#10), Endocrinology and Diabetes (#16), Pulmonology (#19), Nephrology (#21), Geriatrics (#22), and Cancer (#23). The Department of Pathology and Genomic Medicine at Houston Methodist is an academic department that provides anatomic and clinical pathology services to all eight hospitals in the Houston Methodist System. The department has 75 faculty members and approximately 40 residents and fellows. The department is led by James M. Musser, MD, PhD, Chair, and the Fondren Presidential Distinguished Chair.
The Houston Methodist Department of Pathology and Genomic Medicine is seeking a highly qualified scientist to serve as Vice Chair of Research, Molecular Pathogenesis to lead and oversee pathology research programs and faculty. These include activities not only within the department, but cross-departmentally and institutionally throughout the Houston Methodist System and Houston Methodist Research Institute. The individual will have a proven track record of securing NIH and other external funding, leading successful research programs, and developing innovative, forward-thinking, and collaborative research initiatives. Preference will be given to individuals with a track record in translating discoveries from the bench into clinical trials and novel therapeutics, but this is not an essential attribute.
The Vice-Chair will be based at the main campus of Houston Methodist in the heart of the Texas Medical Center, and report directly to the Chair. The department is committed to expanding its reputation as a top-tier academic, research, and educational enterprise. This position offers a unique opportunity to build on our world-class research footprint. For outstanding candidates, a named chair in the department may be possible.
Qualified candidates will be eligible for faculty appointments at the Houston Methodist Academic Institute and Weill Cornell Medical College.
- Candidates will have an MD, PhD, MD/PhD, or equivalent.
- Outstanding research and leadership skills with a national or international reputation.
- History of successfully obtaining longitudinal extramural funding and publishing in high-impact, peer-reviewed journals.
- Track record of overseeing successful research program development, implementation, management, and expansion.
- Excellent personal, interpersonal communication and presentation skills for diverse audiences, including non-clinical and clinical audiences, in group settings or one-on-one.
- Skills in interacting with philanthropic donors and other members of the lay public.
- Scientific expertise in molecular cancer biology, neuropathology, infection pathogenesis, or human immunology will be viewed as a positive attribute.
- Translational expertise coupled with entrepreneurial spirit will be viewed as a positive attribute.
- Development of molecules from bench research through phase II clinical trials will be viewed as a positive attribute.
Houston Methodist Hospital (HMH) is an Equal Opportunity Employer. HMH will not engage in discrimination against or harassment of any person employed or seeking employment with Houston Methodist Hospital on the basis of race, color, religion, sex, sexual orientation, gender identity, national origin, age, disability, status as a protected veteran or other characteristics protected by law. VEVRAA Federal Contractor – priority referral Protected Veterans requested.